Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?
Scheiman
J
J
University of Michigan Medical Center, Ann Arbor, MI, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D015179:Colorectal Neoplasms / Q000517:prevention & control; D004938:Esophageal Neoplasms / Q000517:prevention & control; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D054328:Proton Pump Inhibitors; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D054328:Proton Pump Inhibitors; D001241:Aspirin